IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.650
+0.060 (3.77%)
May 14, 2026, 12:45 PM EDT - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $16.25 million as of May 14, 2026. Its market cap has increased by 16.25% in one year.
Market Cap
16.25M
Enterprise Value
-3.93M
1-Year Change
16.25%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $16.25M, a decrease of -91.34%. That is a compound annual growth rate of -40.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 15.66M | -31.45% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 18.62M |
| SeaStar Medical Holding | 18.31M |
| Cocrystal Pharma | 17.92M |
| Citius Pharmaceuticals | 17.31M |
| Cadrenal Therapeutics | 17.00M |
| Theriva Biologics | 15.65M |
| NewcelX | 15.27M |
| Lexaria Bioscience | 14.99M |